[ET Net News Agency, 27 May 2026] GENSCRIPT BIO (01548) rose 10.6% to HK$14.69.
It hits an intra-day high of HK$14.68, breaking above the 250-D SMA of HK$14.679, and an intra-day low of HK$13.13. The total shares traded was 10.44 million, with a value of HK$146.29m. The active buy/sell ratio is 68:32, with net buying turnover of HK$51.67m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$2.4m, with volume weighted average price of HK$13.973. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$8.79m, with volume weighted average price of HK$14.034. The stock has risen a combined 14.7% over the past 3 consecutive trading days.
Basic Information| Nominal | 14.690 | % Chg | +10.62% |
| High | 14.680 | Low | 13.130 |
| Shares Tr | 10.44m | Turnover | 146.29m |
| 10-D SMA | 13.685 | %H.V | 49.365 |
| 20-D SMA | 13.974 | VWAP | 14.008 |
| 50-D SMA | 12.950 | RSI14 | 60.056 |
Status: Breaking above the 250-D SMA, active buy/sell ratio is 68:32, with net buying turnover of HK$51.67m, rising a combined 14.7% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| GENSCRIPT BIO (01548) | 14.69 | +10.62 |
| INNOVENT BIO (01801) | 79.10 | -0.94 |
| XTALPI (02228) | 8.07 | -3.58 |
| WUXI XDC (02268) | 55.65 | -3.22 |
| WUXI BIO (02269) | 33.90 | -1.40 |
| WUXI APPTEC (02359) | 128.20 | -0.47 |
| TRANSTHERA-B (02617) | 39.30 | -3.25 |
| BEONE MEDICINES (06160) | 181.20 | -2.48 |
| AKESO (09926) | 115.00 | +2.50 |
| REMEGEN (09995) | 81.65 | -2.57 |
(ed)
Nominal 
